Abstract:BACKGROUND:During the transfusion of blood components, the transfer of allogeneic donor white blood cells (WBCs) can mediate transfusion-associated graft-versus-host disease (TA-GVHD). To minimize the reaction, exposure of blood products to gamma irradiation is currently the standard of care. The aim of our study was to evaluate and compare hemostatic function, transfusion efficacy, and safety of gamma-irradiated single-donor apheresis platelet concentrates (PCs) and of conventional non-irradiated PCs in patients with chemotherapy-induced thrombocytopenia. METHODS:20 double-dose single-donor leukoreduced PCs were split in two identical units; one was gamma-irradiated with 25 Gy (study arm A) and the other remains non-irradiated (study arm B). Both units were stored under equal conditions. Hematologic patients were randomly assigned to receive gamma-irradiated or conventional non-irradiated PCs. Hemostatic function was evaluated by thrombelastography (TEG). TEG measurements were taken pre transfusion and 1 and 24 h post transfusion. TEG profiles were measured, noting the time to initiate clotting (R), the angle of clot formation (α), and the maximum amplitude (clot strength (MA)). Whole blood samples were collected from these thrombocytopenic patients at 1 and 24 h for PLT count increments (CIs) and corrected count increments (CCIs) with assessments of transfusion efficacy. Time to next PLT transfusion, transfusion requirement of RBCs, active bleeding, and adverse events (AEs), were analyzed. RESULTS:No differences could be found in hemostatic function parameters (MA, R, and α) between study arms A and B (all p values > 0.096) pre transfusion as well as 1 and 24 h post transfusion. No differences between study arms A and B were observed for mean (± standard deviation (SD)) 1-hour CCI (12.83 ± 6.33 vs. 11.59 ± 5.97) and 24-hour CCI (6.56 ± 4.10 vs. 5.76 ± 4.05). Mean 1-hour CI and 24-hour CI were not significantly different in both study arms (p = 0.254 and p = 0.242 respectively). Median time to the next PC transfusion after study PC was not significantly different between groups: (2.4 vs. 2.2 days, p = 0.767). No differences could be found in transfusion requirement of red blood cells (p = 0.744) between both study arms. There were also no regarding bleeding, adverse events, and acute transfusion reaction(s). CONCLUSIONS:This study confirms safety of gamma-irradiated PCs for treatment thrombocytopenia. Hemostatic function, transfusion efficacy, bleeding, and safety of single-donor apheresis PCs treated with gamma irradiation versus untreated control PCs are comparable.

Analysis of Efficacy of Apheresis Platelets Transfusion on Patients with Haematological Diseases

Comparison of Therapeutic Effect of Apheresis Platelets and Buffy Coat-Derived Platelet Concentrates

Improving platelet function following prophylactic platelet transfusion in patients with hematological malignancies

[Short-Term Effects of Hemogram in Healthy Donors after Peripheral Blood Stem Cell Collection].

Analysis of the factors influencing the efficacy of platelet transfusion

Clinical efficacy of platelet transfusion therapy in patients with leukemia and analysis of risk factors for ineffective transfusion

Qualities and Curative Effects of Single Donor Platelets and Buffy-coat-collected Platelets Concentrates

Therapeutic Plateletpheresis in Patients With Thrombocytosis: Gender, Hemoglobin Before Apheresis Significantly Affect Collection Efficiency

Comparison Between the Clinical Efficacy of Platelet Concentrates, Derived from Buffy Coat and Apheresis in Tumor Patients.

Clinical Application of Therapeutic Hemapheresis and Plasma Exchange in Hematology Diseases

Impact of Plateletpheresis on the Hemoglobin, Hematocrit, and Total Red Blood Cell Count: An Updated Meta-Analysis

Clinical Observation of Factors in the Efficacy of Blood Component Transfusion in Patients Following Hematopoietic Stem Cell Transplantation

Hemostatic function and transfusion efficacy of apheresis platelet concentrates treated with gamma irradiation in use for thrombocytopenic patients.

Correlation analysis between platelet parameters and efficacy of platelet transfusion and prognosis

Clinical Application of Therapeutic Plateletphoresis in Thrombocythemia

[Effect of Artificial Liver with Double Plasma Molecular Absorb System Model on Patients' Platelets and Corresponding Treatment Strategy].

Transfusion of Leukocyte-Depleted Blood in Renal Transplantation

Analysis of Refractoriness to Platelet Transfusion in Patients with Idiopathic Thrombocytopenic Purpura

Study on Impact of Recipients Age on Clinical Platelets Transfusion

Application of the thrombelastogram in the evaluation of coagulation functions pre/post plateletpheresis

Comparative analysis of the quality of platelet concentrates produced by apheresis procedures, platelet rich plasma, and buffy coat